RORDEP Peptides: Is the Gut Microbiota Mimicking Exercise?

🇬🇧 Read this article in English

What if a bacterium in your gut were quietly manufacturing a molecule that mimics the beneficial effects of exercise on body fat, blood sugar and thermogenesis — without you knowing? That is exactly what a study published in Nature Microbiology in August 2025 has just demonstrated, opening an entirely new field: that of hormone-like bacterial peptides.

From a common bacterium to an irisin mimic

The team of Yang and colleagues (Pedersen group, Copenhagen) screened the proteins encoded by the bacteria of the human gut microbiota, looking for sequences resembling human hormones. Among thousands of candidates, two peptides drew their attention. Both are derived from a single bacterial protein, RUMTOR_00181, produced by Ruminococcus torques, a bacterium found in almost all humans. The researchers named them RORDEP1 and RORDEP2, for Ruminococcus torques-Derived Peptides.

Their molecular signature is striking: these peptides share 24 to 25% sequence identity with irisin, a human hormone released by muscle during physical exercise. Irisin, identified in 2012 by Bruce Spiegelman’s team, results from the cleavage of the FNDC5 protein and triggers the “browning” of white adipose tissue, increases thermogenesis and improves insulin sensitivity. RORDEP1 and RORDEP2 carry the same structural domains — the FN3 domains (fibronectin type III) — that underlie irisin’s biological activity.

Why this discovery is a game-changer

1. Proof that the microbiota “talks” to metabolism through hormone-like peptides

Until now, the microbiota ↔ host dialogue was mainly explained by bacterial metabolites (short-chain fatty acids, secondary bile acids, tryptamine, etc.). With RORDEP, we cross a threshold: bacteria in our digestive tract manufacture peptides that directly mimic a human hormone. The microbiota no longer merely modulates our signals — it emits them.

2. A consistent correlation in humans

In human cohorts, the abundance of RORDEP-producing bacteria is inversely correlated with BMI and fat mass. In other words: the more you have, the more metabolically favorable you tend to be. This is a correlation, not yet causation, but it is consistent with the biological effects measured.

3. A reproducible effect using a “medicine” bacterium

The authors engineered Escherichia coli Nissle 1917, a probiotic strain already used clinically, to express RORDEP1. When administered to obese mice, this bacterium reproduced most of the observed metabolic effects. This is a proof of concept for living biotherapeutics targeting metabolism.

Measured preclinical effects: an overview

Compartment	Observed effect (HFD mice ± RORDEP)
Blood glucose	↑ glucose tolerance, ↑ insulin sensitivity
Adipose tissue	↓ fat mass, ↑ thermogenesis (UCP1, Prdm16, Dio2)
Gut hormones	↑ GLP-1, ↑ PYY, ↑ insulin, ↓ GIP (–50%)
Liver	↓ hepatic glucose production (–40%)
Bone	↑ bone density
Body weight	↓ weight gain on a high-fat diet

The hormonal profile is particularly interesting: the GLP-1 ↑ / GIP ↓ combination broadly recalls the mechanism sought by the new pharmacological agonists (tirzepatide, conversely, is a dual GLP-1/GIP agonist — the physiology remains to be clarified). As for the thermogenic signature UCP1 / Prdm16 / Dio2, it is the very hallmark of white adipose tissue browning, the classic irisin pathway.

What can you concretely do to favor Ruminococcus torques?

No intervention has been directly validated to increase RORDEP in humans. But R. torques belongs to the broad family of bacteria that degrade the intestinal mucus layer and ferment complex fibers. The general, high-consensus levers remain:

• Plant diversity: aim for 30 different plant species per week (vegetables, fruit, legumes, nuts and seeds, herbs, spices, whole grains).
• Fermentable fibers: 25–35 g/day, including prebiotics (chicory, Jerusalem artichoke, asparagus, onion, garlic, slightly unripe banana).
• Polyphenols: berries, green tea, unsweetened cocoa, virgin olive oil — selective substrates for beneficial bacteria.
• Fermented foods (unpasteurized): kefir, live yogurts, raw sauerkraut, kimchi.
• Regular physical activity: changes the composition of the microbiota and increases endogenous irisin production.
• Avoid avoidable disruptors: unnecessary antibiotic use, excessive alcohol, ultra-processed foods, chronic sleep deprivation.

Where do the trials stand?

To date (May 2026), no registered clinical trial is testing RORDEP in humans. The plausible avenues in the coming years are:

• microbiota–metabolism association studies stratified by R. torques abundance and plasma RORDEP levels;
• trials of next-generation probiotics (genetically modified E. coli Nissle 1917, or selected commensal strains) producing targeted peptides;
• exploration of synthetic RORDEP peptides in pharmacology, modeled on other metabolic peptidomimetics.

What this changes for our view of the microbiota

RORDEP reinforces an already solid idea: the gut microbiota is an endocrine organ in its own right. It no longer merely ferments our fibers and modulates inflammation: it synthesizes molecules with hormonal activity that enter the circulation and act on the liver, the gut, adipose tissue and bone. This discovery paves the way for a whole family of bacterial peptides with hormonal activity (RiPPs and homologs), part of which remains to be discovered.

The NutriCellScience perspective

This study is exciting for its methodological rigor: proteomic screening of the microbiota, confirmation in mice, plasma detection in humans, reproduction with an engineered probiotic. The body of evidence is coherent.

But the most important lesson for today, in practice, is probably the simplest one: a diverse microbiota, fed with fiber and polyphenols, challenged by regular physical activity, remains the most robust strategy to optimize your metabolism. RORDEP is just one more — elegant — reason to stick with it.

On the other hand, we avoid giving in to the marketing temptation: to date, no dietary supplement can claim to provide RORDEP, to selectively increase R. torques, or to “activate” the bacterial irisin pathway. Any such claim, in 2026, is premature.

---

Primary references

• Yang Y. et al. Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism. Nat Microbiol. 2025 Aug;10(8):1918-1939. nature.com · PubMed 40745048 · DOI: 10.1038/s41564-025-02064-x · Code: github.com/fjw536/RORDEP
• Boström P. et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463-468. PubMed 22237023 — landmark irisin study.
• Luis A.S. et al. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein. mBio. 2024. PubMed 38975756
• (2025) Ruminococcus torques alleviates inflammatory bowel disease via bile acid metabolism. J Transl Med. PubMed 41131583
• He B. et al. Large-scale discovery of ribosomally synthesized and post-translationally modified peptides (RiPPs) in the human gut microbiome. Nat Commun. 2025. nature.com

— NutriCellScience, Mark DOWN

---

Further reading

• Cluster IV: the gut’s anti-inflammatory bacteria
• Akkermansia: the gut bacterium fascinating metabolic research
• Resistant starch: the hidden carb that feeds your microbiome
• Clostridium leptum: the silent guardian of your gut